coronavirus
caus
two
largescal
pandem
past
two
decad
sar
middl
east
respiratori
syndrom
mer
gener
thought
mainli
found
caus
futur
diseas
report
seri
case
caus
unidentifi
pneumonia
diseas
outbreak
wuhan
hubei
provinc
central
china
diseas
start
local
seafood
grown
substanti
infect
peopl
china
associ
death
led
infect
peopl
addit
countri
januari
typic
clinic
symptom
patient
fever
dri
cough
breath
difficulti
dyspnoea
headach
pneumonia
diseas
onset
may
result
progress
respiratori
failur
owe
alveolar
damag
observ
transvers
chest
computerizedtomographi
imag
even
death
diseas
determin
caus
virusinduc
pneumonia
clinician
accord
clinic
symptom
criteria
includ
rise
bodi
temperatur
decreas
number
lymphocyt
white
blood
cell
although
level
latter
sometim
normal
new
pulmonari
infiltr
chest
radiographi
obviou
improv
treatment
antibiot
three
day
appear
earli
case
contact
histori
origin
seafood
market
howev
diseas
progress
transmit
humantohuman
contact
sampl
seven
patient
sever
pneumonia
six
seller
deliverymen
seafood
market
admit
intens
care
unit
wuhan
jin
yintan
hospit
begin
outbreak
sent
laboratori
wuhan
institut
virolog
wiv
diagnosi
caus
pathogen
extend
data
tabl
laboratori
investig
cov
first
use
pancov
pcr
primer
test
given
outbreak
occur
winter
environ
sar
infect
found
five
sampl
pcrposit
cov
one
sampl
collect
bronchoalveolar
lavag
fluid
balf
analys
metagenom
analysi
use
nextgener
sequenc
identifi
potenti
aetiolog
agent
total
total
read
retain
filter
read
human
sequenc
match
sequenc
sarsrcov
fig
de
novo
assembl
target
pcr
obtain
cov
genom
share
sequenc
ident
sarscov
genbank
access
number
high
genom
coverag
obtain
remap
total
read
genom
extend
data
fig
sequenc
submit
gisaid
http
wwwgisaidorg
access
number
follow
name
given
world
health
organ
tent
call
novel
coronaviru
four
fulllength
genom
sequenc
gisaid
access
number
ident
subsequ
obtain
four
addit
patient
use
nextgener
sequenc
pcr
extend
data
tabl
viru
genom
consist
six
major
openread
frame
orf
common
coronavirus
number
accessori
gene
fig
analysi
indic
gene
share
less
nucleotid
sequenc
ident
sarscov
howev
amino
acid
sequenc
seven
conserv
replicas
domain
use
cov
speci
classif
ident
sarscov
suggest
two
virus
belong
speci
sarsrcov
found
short
region
rnadepend
rna
polymeras
rdrp
bat
coronaviru
batcov
previous
detect
rhinolophu
affini
yunnan
high
sequenc
ident
carri
fulllength
sequenc
rna
sampl
gisaid
access
number
simplot
analysi
show
highli
similar
throughout
genom
fig
overal
genom
sequenc
ident
use
align
genom
sequenc
sarscov
previous
report
bat
sarsrcov
evid
recombin
event
detect
genom
phylogenet
analysi
fulllength
genom
gene
sequenc
rdrp
spike
show
closest
rel
form
distinct
lineag
sarsrcov
fig
extend
data
fig
receptorbind
spike
protein
encod
gene
highli
diverg
cov
extend
data
fig
less
nucleotid
sequenc
ident
previous
describ
sarsrcov
except
nucleotid
ident
extend
data
tabl
gene
longer
sarsrcov
major
differ
sequenc
gene
three
short
insert
ntermin
domain
well
chang
four
five
key
residu
receptorbind
motif
compar
sequenc
sarscov
extend
data
fig
whether
insert
ntermin
domain
protein
confer
sialicacidbind
activ
merscov
need
studi
close
phylogenet
relationship
provid
evid
may
origin
bat
rapidli
develop
qpcrbase
detect
method
basi
sequenc
receptorbind
domain
gene
variabl
region
genom
fig
data
show
primer
could
differenti
human
coronavirus
includ
bat
sarsrcov
share
ident
sarscov
extend
data
fig
b
sampl
obtain
seven
patient
found
six
balf
five
oral
swab
sampl
posit
first
sampl
assess
qpcr
convent
pcr
howev
could
longer
detect
virusposit
sampl
oral
swab
anal
swab
blood
sampl
taken
patient
second
sampl
fig
howev
recommend
qpcr
target
includ
rdrp
envelop
e
gene
use
routin
detect
basi
find
propos
diseas
could
transmit
airborn
transmiss
although
rule
possibl
rout
transmiss
investig
includ
patient
requir
serolog
detect
use
previous
develop
nucleocapsid
n
protein
bat
sarsrcov
antigen
igg
igm
enzymelink
immunosorb
assay
elisa
protein
share
amino
acid
ident
n
protein
extend
data
fig
show
crossreact
human
coronavirus
except
abl
obtain
five
serum
sampl
seven
patient
viral
infect
monitor
viral
antibodi
level
one
patient
day
onset
diseas
extend
data
tabl
clear
trend
observ
igg
igm
titr
increas
time
except
igm
titr
decreas
last
sampl
fig
second
analysi
test
sampl
virusposit
patient
around
day
diseas
onset
presenc
viral
antibodi
extend
data
tabl
patient
sampl
healthi
strongli
posit
viral
igg
fig
also
three
igmposit
sampl
indic
acut
infect
next
success
isol
viru
call
vero
cell
use
balf
sampl
patient
clear
cytopathogen
effect
observ
cell
incub
three
day
extend
data
fig
b
ident
strain
verifi
vero
cell
immunofluoresc
microscopi
use
crossreact
viral
n
antibodi
extend
data
fig
metagenom
sequenc
read
map
qpcr
analysi
show
viral
load
increas
day
day
extend
data
fig
f
viral
particl
ultrathin
section
infect
cell
display
typic
coronaviru
morpholog
visual
electron
microscopi
extend
data
fig
confirm
neutral
activ
viral
iggposit
sampl
conduct
serumneutr
assay
vero
cell
use
five
patient
sera
iggposit
demonstr
sampl
abl
neutral
tissuecultureinfect
dose
dilut
also
show
viru
could
crossneutr
hors
antisarscov
serum
gift
lf
wang
dilut
howev
potenti
crossreact
sarscov
antibodi
need
confirm
antisarscov
serum
human
extend
data
tabl
known
cell
receptor
determin
whether
also
use
cellular
entri
receptor
conduct
viru
infect
studi
use
hela
cell
express
express
protein
human
chines
horsesho
bat
civet
pig
mice
show
abl
use
protein
except
mous
entri
receptor
enter
cell
cell
express
indic
probabl
cell
receptor
enter
cell
fig
also
show
use
coronaviru
receptor
aminopeptidas
n
apn
dipeptidyl
peptidas
extend
data
fig
studi
provid
detail
report
like
aetiolog
agent
respons
ongo
epidem
acut
respiratori
syndrom
china
countri
virusspecif
nucleotideposit
viralprotein
seroconvers
observ
patient
test
provid
evid
associ
diseas
presenc
viru
howev
still
mani
urgent
question
remain
answer
associ
diseas
verifi
anim
experi
fulfil
koch
postul
establish
caus
relationship
microorgan
diseas
yet
know
transmiss
routin
viru
among
host
appear
viru
becom
transmiss
human
close
monitor
whether
viru
continu
evolv
becom
virul
owe
shortag
specif
treatment
consid
related
sarscov
drug
preclin
vaccin
sarscov
could
probabl
use
treat
viru
final
consid
wide
spread
sarsrcov
natur
reservoir
futur
research
focus
activ
surveil
virus
broader
geograph
region
long
term
broadspectrum
antivir
drug
vaccin
prepar
emerg
infecti
diseas
caus
cluster
virus
futur
importantli
strict
regul
domest
consumpt
wildlif
implement
note
ad
proof
sinc
paper
accept
ictv
design
viru
addit
releas
offici
name
diseas
caus
viru
statist
method
use
predetermin
sampl
size
experi
random
investig
blind
alloc
experi
outcom
assess
human
sampl
includ
oral
swab
anal
swab
blood
balf
sampl
collect
jinyintan
hospit
wuhan
china
consent
patient
approv
ethic
committe
design
hospit
emerg
infecti
diseas
patient
sampl
without
gender
age
prefer
unless
indic
swab
ml
dmem
contain
fb
ad
tube
supernat
collect
centrifug
rpm
vortex
stand
period
min
supernat
swab
balf
pretreat
ad
either
lysi
buffer
rna
extract
viral
transport
medium
isol
viru
viral
transport
medium
compos
hank
balanc
salt
solut
ph
contain
bsa
amphotericin
penicillin
g
unit
streptomycin
serum
separ
centrifug
min
within
h
collect
follow
inactiv
h
store
use
follow
cell
line
use
viru
isol
studi
vero
cell
cultur
dmem
contain
fb
cell
line
test
free
mycoplasma
contamin
submit
speci
identif
authent
morpholog
evalu
microscopi
none
cell
line
list
commonli
misidentifi
cell
line
iclac
cultur
cell
monolay
maintain
respect
medium
pcrposit
balf
sampl
patient
spun
min
filter
dilut
dmem
supplement
trypsin
ad
cell
incub
h
inoculum
remov
replac
fresh
cultur
medium
contain
antibiot
see
trypsin
cell
incub
observ
daili
cytopathogen
effect
cultur
supernat
examin
presenc
viru
method
develop
studi
cell
examin
immunofluoresc
microscopi
use
antisarsrcov
n
antibodi
gener
inhous
penicillin
unit
streptomycin
includ
tissu
cultur
media
vero
cell
infect
new
viru
multipl
infect
moi
collect
h
infect
cell
fix
wv
glutaraldehyd
osmium
tetroxid
dehydr
grade
seri
ethanol
concentr
embed
epoxi
resin
ultrathin
section
nm
embed
cell
prepar
deposit
onto
formvarco
copper
grid
mesh
stain
uranyl
acet
lead
citrat
analys
use
tecnai
electron
microscop
viru
neutral
test
carri
plate
patient
serum
sampl
heatinactiv
incub
h
use
serum
sampl
dilut
equal
volum
viru
stock
ad
incub
min
incub
dilut
hors
antisarscov
serum
serum
sampl
healthi
individu
use
control
incub
mixtur
inocul
onto
monolay
vero
cell
plate
h
serum
assess
triplic
remov
supernat
plate
wash
twice
dmem
medium
cell
incub
dmem
supplement
fb
day
subsequ
cell
check
cytopathogen
effect
whenev
commerci
kit
use
manufactur
instruct
follow
without
modif
rna
extract
sampl
high
pure
viral
rna
kit
roch
rna
elut
elut
buffer
use
templat
qpcr
analysi
primer
base
gene
design
rna
extract
describ
use
qpcr
use
hiscript
ii
one
step
sybr
green
kit
vazym
biotech
convent
pcr
also
perform
use
follow
primer
pair
qpcr
reaction
mix
contain
one
step
sybr
green
mix
one
step
sybr
green
enzym
mix
rox
refer
dye
primer
templat
rna
amplif
perform
follow
min
follow
cycl
consist
default
melt
curv
step
abi
realtim
pcr
machin
inhous
antisarsrcov
igg
igm
elisa
kit
develop
use
sarsrcov
n
protein
antigen
share
amino
acid
ident
igg
analys
maxisorp
nuncimmuno
elisa
plate
coat
ng
per
well
overnight
recombin
n
protein
human
sera
use
dilut
h
antihuman
igg
hrpconjug
monoclon
antibodi
kyab
biotech
use
dilut
od
valu
nm
calcul
igm
analys
maxisorp
nuncimmuno
elisa
plate
coat
ng
per
well
overnight
antihuman
igm
chain
human
sera
use
dilut
min
follow
incub
n
hrpconjug
antibodi
kyab
biotech
dilut
od
valu
nm
calcul
hela
cell
transient
express
prepar
use
lipofectamin
thermo
fisher
scientif
plate
mocktransfect
cell
use
control
grown
vero
cell
use
infect
moi
apn
analys
way
inoculum
remov
absorpt
h
wash
twice
pb
supplement
medium
h
infect
cell
wash
pb
fix
formaldehyd
pb
ph
min
room
temperatur
express
detect
use
mous
anti
tag
monoclon
antibodi
fitclabel
goat
antimous
igg
h
l
abcam
viral
replic
detect
use
rabbit
antibodi
n
protein
gener
inhous
goat
antirabbit
igg
abcam
nuclei
stain
dapi
beyotim
stain
pattern
examin
use
confoc
microscopi
microscop
olympu
sampl
patient
balf
supernat
viru
cultur
use
rna
extract
nextgener
sequenc
ng
use
bgi
illumina
miseq
sequenc
metagenom
analysi
carri
mainli
base
bioinformat
platform
mgmapper
raw
ng
read
first
process
cutadapt
minimum
read
length
base
pair
bwa
use
align
read
local
databas
filter
hit
paramet
fmm
match
mismatch
read
length
fraction
valu
minimum
align
score
paramet
postprocess
assign
read
set
minimum
size
normal
abund
minimum
read
count
otherwis
set
default
paramet
local
nucleic
acid
databas
human
mammal
use
filter
read
host
genom
map
read
viru
databas
result
metagenom
analysi
display
pie
chart
use
microsoft
offic
ng
read
assembl
genom
use
geneiou
megahit
pcr
sanger
sequenc
perform
fill
gap
genom
amplif
cdna
end
race
perform
determin
genom
use
smarter
race
kit
takara
genom
annot
use
clone
manag
profession
suit
sci
softwar
routin
sequenc
manag
analysi
carri
use
dnastar
sequenc
align
complet
genom
sequenc
perform
use
mafft
default
paramet
codon
align
fulllength
rdrp
gene
sequenc
convert
correspond
protein
align
protein
align
creat
clustal
omega
use
default
paramet
maximum
likelihood
phylogenet
tree
gener
use
raxml
gtrg
substitut
model
bootstrap
replic
inform
research
design
avail
natur
research
report
summari
link
paper
method
addit
refer
natur
research
report
summari
sourc
data
extend
data
supplementari
inform
acknowledg
peer
review
inform
detail
author
contribut
compet
interest
statement
data
code
avail
avail
